Acetylcholine

Acetylcholine helps nerves control muscles and organs and supports attention and memory. Measuring it in urine is a separate question: researchers haven't established how a urine result relates to the amount released at nerve connections or how well those signals work.

This is a research-stage measurement. Small human studies have explored links with bladder symptoms and cognitive impairment, but there are no validated thresholds for diagnosis or treatment, or trials showing that using the result improves health. A laboratory can measure the molecule accurately without establishing what you should do with the number.

A Messenger That Barely Lasts

Nerve cells make acetylcholine from choline. Choline is a nutrient supplied by food and also made in limited amounts by the body. After acetylcholine carries a signal, acetylcholinesterase rapidly breaks it down into choline and acetate. Butyrylcholinesterase can also break it down. These enzymes help limit how long its effects last.

Where the Urine Signal Comes From

A study of urine from people with normal bladder function found no significant net addition of acetylcholine as urine passed through the lower urinary tract. The authors concluded that urinary acetylcholine reflects acetylcholine the kidneys extract from blood. They didn't directly trace its origin, and the findings don't establish what happens in bladder or kidney disease.

A separate study using LC-MS/MS found that acetylcholine excretion in urine was associated with choline concentrations in blood plasma, in both men and women. The same method couldn't detect acetylcholine in plasma itself. That association doesn't establish that this test measures your choline intake, nutritional needs, or total acetylcholine production.

Bladder Symptoms

In a small study of women with overactive bladder, higher urinary acetylcholine before treatment was associated with a better later response to medication that blocks acetylcholine's effects. A 2022 follow-up from the same group, in 39 women with urgency incontinence and 33 controls, found the same direction: women who responded to treatment had higher baseline acetylcholine. Women with urgency incontinence also had higher urinary acetylcholine and choline than controls. That study used commercial assay kits rather than LC-MS, so its numbers can't be compared with an LC-MS result. Neither study established how treatment changes urinary acetylcholine or validated a rule for choosing medication.

These findings support further study of a possible bladder marker. They don't establish urinary acetylcholine as a diagnostic test for urgency, leakage, or bladder pain.

Memory and Dementia

Damage to acetylcholine-producing nerve cells occurs in Alzheimer's disease and dementia with Lewy bodies. That makes the molecule biologically relevant, but it doesn't establish urine as a measure of those brain changes.

A study comparing 30 people with mild cognitive impairment with 30 controls included urinary acetylcholine among chemicals associated with cognitive status. It used LC-MS/MS to examine hundreds of compounds and their relationships. This was an exploratory comparison, not a validated standalone test or a study showing that a urine result predicts future dementia.

Research in spinal fluid provides another caution, although it measures a different body fluid. The older spinal-fluid studies conflict. A 1994 study reported about 73% lower acetylcholine in Alzheimer's disease, while a 1998 study found lower average values that weren't statistically reliable, with many samples below the detection limit. More recent researchers attribute the earlier reports of decreases partly to limited sensitivity and method problems in older techniques. In a 2025 study of 214 people, acetylcholine measured by LC-MS/MS did not differ significantly between Alzheimer's disease, dementia with Lewy bodies, and neurological control groups. None of these studies validates a urine test.

Heart Disease and Choline

Some cardiovascular research concerns choline in blood, which is a different molecule in a different specimen. A meta-analysis pooling 17 studies of choline and betaine included about 33,000 people. In the analyses of circulating choline, the highest groups had about 29% greater cardiovascular risk than the lowest groups. Their risk of death from any cause was about 62% higher. These were associations and don't establish that choline caused the outcomes.

A separate study found lower plasma acetylcholine and choline in people awaiting coronary bypass surgery than in healthy controls. That runs opposite to the meta-analysis, where higher circulating choline went with higher risk. Acetylcholine wasn't among the urine compounds that study reported as different, and it didn't show that urinary acetylcholine predicts heart disease. With blood findings pointing in opposite directions, there is no basis for deciding that a higher or lower urine result is healthier.

When Results Can Be Misleading

This test uses liquid chromatography with mass spectrometry, abbreviated LC-MS. The method separates chemicals in urine and detects them using their mass and electrical charge. It can distinguish acetylcholine from choline when the assay is properly designed. Research protocols include LC-MS/MS and differ in sample preparation and reporting, so published values can't automatically be applied to your result. Methods disagree even in blood: one LC-MS/MS method couldn't detect plasma acetylcholine at all, while another study reported lower plasma levels in heart patients.

• Sample handling: breakdown before analysis can alter the amount recovered. Research protocols have used prompt freezing, but an acceptable storage time and temperature must come from the laboratory's validation for its collection kit.
• Urine concentration and reporting: dilution affects concentrations. The reported unit is mcg/g, and the report needs to identify what the gram refers to. If the denominator is creatinine, the result is already adjusted for that urine measurement.
• Kidney handling: the kidneys may contribute to variation in the result. There is no validated way to infer kidney disease or adjust this test for impaired filtration.
• Analytical limits: abundant choline, other substances in urine, and concentrations near the assay's measurement limit can complicate analysis. Gamma-butyrobetaine, a natural compound with the same chemical formula as acetylcholine, can be mistaken for it unless the method separates the two. LC-MS still requires appropriate separation, calibration, and checks for interference.

A result below the assay's measurement limit doesn't establish that the molecule is absent. Differences between laboratories can reflect their methods or reporting conventions. Neither a laboratory flag nor a change from your previous result establishes deficient or excessive acetylcholine signaling.